Skip to main content
TipRanks
Go Ultimate75% OFF

Proteomics International Laboratories Ltd. (PIQ) Stock Statistics & Valuation Metrics

33 Followers

Total Valuation

Proteomics International Laboratories Ltd. has a market cap or net worth of AUD 16.21M. The enterprise value is AUD 99.81M.

Market Cap
AUD 16.21M
Enterprise Value
AUD 99.81M

Share Statistics

Proteomics International Laboratories Ltd. has 165,373,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
165,373,120
Owned by Insiders
11.29%
Owned by Institutions
―

Financial Efficiency

Proteomics International Laboratories Ltd.’s return on equity (ROE) is -1.47 and return on invested capital (ROIC) is -132.04%.

Return on Equity (ROE)
-1.47
Return on Assets (ROA)
-0.96
Return on Invested Capital (ROIC)
-132.04%
Return on Capital Employed (ROCE)
-1.70
Revenue Per Employee
1,726.801
Profits Per Employee
-53.17K
Employee Count
161
Asset Turnover
0.03
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Proteomics International Laboratories Ltd. is -1.72. Proteomics International Laboratories Ltd.’s PEG ratio is -2.72.

PE Ratio
-1.72
PS Ratio
59.48
PB Ratio
2.03
Price to FCF
-2.10
Price to Operating Cash Flow
-2.01
PEG Ratio
-2.72

Income Statement

In the last 12 months, Proteomics International Laboratories Ltd. had revenue of 278.01K and earned -8.56M in profits. Earnings per share was -0.05.

Revenue
278.01K
Gross Profit
-9.07M
Operating Income
-11.89M
Pretax Income
-10.78M
Net Income
-8.56M
EBITDA
-11.08M
Earnings Per Share (EPS)
-0.05

Cash Flow

In the last 12 months, operating cash flow was -5.87M and capital expenditures -2.01M, giving a free cash flow of -7.88M billion.

Operating Cash Flow
-5.87M
Free Cash Flow
-7.88M
Free Cash Flow per Share
-0.07

Dividends & Yields

Proteomics International Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-47.66%
Earnings Yield
-72.63%

Stock Price Statistics

Beta
1.19
52-Week Price Change
-70.59%
50-Day Moving Average
0.12
200-Day Moving Average
0.19
Relative Strength Index (RSI)
39.24
Average Volume (3m)
110.22K

Important Dates

Proteomics International Laboratories Ltd. upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

Proteomics International Laboratories Ltd. as a current ratio of 3.19, with Debt / Equity ratio of 5.70%

Current Ratio
3.19
Quick Ratio
3.19
Debt to Market Cap
0.01
Net Debt to EBITDA
0.29
Interest Coverage Ratio
-288.41

Taxes

In the past 12 months, Proteomics International Laboratories Ltd. has paid -2.17M in taxes.

Income Tax
-2.17M
Effective Tax Rate
0.20

Enterprise Valuation

Proteomics International Laboratories Ltd. EV to EBITDA ratio is -1.21, with an EV/FCF ratio of -1.70.

EV to Sales
48.09
EV to EBITDA
-1.21
EV to Free Cash Flow
-1.70
EV to Operating Cash Flow
-2.28

Balance Sheet

Proteomics International Laboratories Ltd. has AUD 3.50M in cash and marketable securities with AUD 331.13K in debt, giving a net cash position of AUD 3.17M billion.

Cash & Marketable Securities
AUD 3.50M
Total Debt
AUD 331.13K
Net Cash
AUD 3.17M
Net Cash Per Share
AUD 0.02
Tangible Book Value Per Share
AUD 0.05

Margins

Gross margin is -3262.02%, with operating margin of -4275.74%, and net profit margin of -3078.86%.

Gross Margin
-3262.02%
Operating Margin
-4275.74%
Pretax Margin
-3878.38%
Net Profit Margin
-3078.86%
EBITDA Margin
-3984.42%
EBIT Margin
-4275.74%

Analyst Forecast

The average price target for Proteomics International Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-23.71%
EPS Growth Forecast
-16.02%

Scores

Smart Score
1
AI Score
45